Monday, July 13, 2015 12:48:50 PM
CBOE has already made available $10 Puts and Calls, Nov 15 & Feb 16, because the stock is expected to perform near that area. They are expected to began blowing out earnings into next year especially after launching their NEO Lab genetic test and the up coming Prostate Liquid Biopsy. The best play here is front month near the money calls if you like risk, in the money 2016 if you don't. Half my NEO position is in options because they give you a better bang for your buck its been working so far.
Recent NEO News
- NeoGenomics to Present New Research at ASCO Annual Meeting 2026 • Business Wire • 05/26/2026 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 08:19:44 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:05:31 PM
- NeoGenomics to Participate in Upcoming Investor Conferences • Business Wire • 05/15/2026 01:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:19:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:18:56 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/07/2026 08:34:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:27:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:27:19 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 03:41:23 PM
- NeoGenomics Shares Jump on Earnings and Analyst Upgrades • IH Market News • 04/29/2026 11:27:26 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/28/2026 09:01:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:59:44 PM
- NeoGenomics Reports First Quarter 2026 Results • Business Wire • 04/28/2026 08:05:00 PM
- NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration • Business Wire • 04/23/2026 11:05:00 AM
- NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 • Business Wire • 04/13/2026 11:05:00 AM
- NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 • Business Wire • 04/07/2026 11:05:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/06/2026 08:26:16 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/06/2026 08:25:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 08:22:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:39:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:38:47 PM
- NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling • Business Wire • 03/16/2026 11:05:00 AM
